Clinical Trial Detail

NCT ID NCT04092673
Title Study of eFT226 in Subjects With Selected Advanced Solid Tumor Malignancies
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Effector Therapeutics
Indications

Advanced Solid Tumor

pancreatic adenocarcinoma

Therapies

eFT226

Age Groups: senior adult

Additional content available in CKB BOOST